Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 44 clinical trials
  • 0 views
  • 25 Oct, 2022
Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants Extended

anticoagulants (DOAC; apixaban, dabigatran, edoxaban, and rivaroxaban) and to determine the diagnostic accuracy of POCT to rule out or detect relevant levels of DOAC in real-life stroke patients. Relevant levels

  • 0 views
  • 12 Sep, 2021
  • 1 location
Non-Interventional Study on Effectiveness of Elxaban Tab. in Patients With Non-valvular Atrial Fibrillation

apixaban) who visit hospital. The purpose is to analyze bleeding (major bleeding, minor bleeding), stroke, systemic embolism, death, other clinical events (acute myocardial infarction, pulmonary embolism

infarct
apixaban
embolism
transient ischemic attack
stroke
  • 11 views
  • 24 Feb, 2022
  • 1 location
Registry of Patients Prescribed Anticoagulation (STAGPOR)

" agents: warfarin and heparinoids and the newer direct oral anticoagulants (DOACs) such as rivaroxaban, dabigatran, apixaban, and edoxaban.

  • 21 views
  • 07 Oct, 2022
  • 1 location
Baseline Concentration of Direct Oral Anticoagulant and Incidence of Adverse Event Measure And See (MAS) (MAS)

The MAS Study is an observational, multicentre, prospective cohort study in Non valvular Atrial fibrillation (NVAF) patients treated with one of the direct oral anticoagulants (DOACs) available in Italy for NVAF patients. The general aim is to deepen the knowledge of DOAC treatment in NVAF patients, by measuring the plasma …

anticoagulants
anticoagulation therapy
fibrillation
  • 1 views
  • 04 Oct, 2022
  • 1 location
The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment (PROFILE)

Prostate cancer is now the commonest cancer in men in the Western world, with over 49,000 new cases diagnosed each year and a lifetime risk of 1 in 11 in the United Kingdom. Prostate cancer (PrCa) can run in some families and research studies have identified several genetic changes in …

Accepts healthy volunteers
prostate cancer screening
prostate specific antigen
  • 1 views
  • 25 Apr, 2022
  • 1 location
Bariatric Surgery and Pharmacokinetics of Apixaban

study we investigate the pharmacokinetic effects of bariatric surgery on apixaban.

bariatric surgery
gastric ph
gastrectomy
gastrointestinal transit
gastric bypass
  • 27 views
  • 27 Feb, 2022
  • 1 location
Apixaban in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study (PROTECT_AR)

The purpose of this study is to evaluate the safety and efficacy of apixaban for the prevention of thromboembolism in adult patients with congenital heart disease (CHD) and non-valvular atrial

arrhythmia
apixaban
thromboembolism
  • 4 views
  • 09 Feb, 2022
  • 8 locations
Andexanet Alfa: Non-interventional Study in Stroke Units in Germany (DE) (ASTRO-DE)

anticoagulation with rivaroxaban or apixaban. The aim of the study is to analyze under routine conditions wether the volume increase of ICH under treatment with rivaroxaban and apixaban can be reduced with

anticoagulation therapy
andexanet
apixaban
rivaroxaban
stroke
  • 0 views
  • 23 May, 2022
  • 2 locations
Monitoring of NOAC Therapy: Standardizing Reference Intervals

This study is aimed to establish reference intervals of NOAC (dabigatran, apixaban and rivaroxaban) in ethnic Chinese patients.

Accepts healthy volunteers
  • 0 views
  • 07 Jun, 2022
  • 1 location